相关实验视频
Updated: Jul 23, 2025

08:15
Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
30.9K
在患有MNGIE的患者中特有的胃肠道运动功能障碍
Luis G Alcalá-González1,2,3, Anna Accarino1,2,3, Ramon Martí4,5
1Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Neurogastroenterology and motility
|July 14, 2023
概括
线粒体神经胃肠道脑膜病变 (MNGIE) 患者表现出明显的小肠运动功能障碍,即使有轻微的症状. 早期调查至关重要,因为症状不能预测这种罕见疾病的客观发现.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 线粒体神经胃肠道脑膜病变 (MNGIE) 是一种罕见的遗传疾病,由TYMP基因突变引起.
- 它会导致严重的胃肠道动力障碍,缓冲症和神经病变.
- 在MNGIE中,胃肠道运动功能障碍需要进行系统评估.
研究的目的:
- 在MNGIE患者中描述胃肠道运动功能障碍.
- 使用先进技术,将运动异常与临床症状相关联.
主要方法:
- 在西班牙国家转诊中心对MNGIE患者的前性研究 (2018年1月 - 2022年7月).
- 评估包括高分辨率测量仪 (食道和小肠) 和胃排空扫描仪.
- 对消化系统症状的评估,以及客观的运动功能测试.
主要成果:
- 评估了五名MNGIE患者 (16-46岁).
- 在4/5的患者中,食道运动异常.
- 小肠计量显示,所有患者都有一个独特的不运动模式 (性收缩).
- 在4/5的患者中,胃排空延迟.
- 客观运动功能障碍存在,即使有轻度或缺少严重的消化系统症状.
结论:
- MNGIE患者表现出特有的运动功能障碍,特别是在小肠.
- 这种功能障碍无论症状严重程度或肠衰竭的形态征兆如何,都会发生.
- 建议进行早期调查,因为症状不能可靠地预测客观的运动发现.
相关概念视频
Gastrointestinal Motility Disorders
452
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
452
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
405
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
405
Enteric Nervous System: Regulation of GI Motor Activity
473
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
473
Gastric Motility
847
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
847
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
313
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
313
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
201
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
201

